Latest Asx Listing News

Page 12 of 170
4DS Memory Limited has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information but highlighting ongoing strategic discussions in AI-related technology.
Sophie Babbage
Sophie Babbage
19 Feb 2026
Ronin Resources has clarified the cause behind recent unusual trading activity, confirming no undisclosed information and announcing the end of negotiations on a potential copper-gold project in Argentina.
Maxwell Dee
Maxwell Dee
19 Feb 2026
DigitalX Limited reports a robust treasury portfolio valued at A$68.2 million, maintaining significant Bitcoin exposure despite a turbulent January in digital asset markets.
Claire Turing
Claire Turing
19 Feb 2026
Tungsten Mining has secured $53 million to push its Mt Mulgine Project through critical feasibility stages while engaging international partners for processing and offtake. The company is positioning itself as a key player in the global tungsten market with strategic moves in the US and Europe.
Maxwell Dee
Maxwell Dee
19 Feb 2026
InvestSMART Group Ltd reports a solid half-year performance with funds under management reaching $750 million and a growing subscriber base, while outlining plans to enhance its digital wealth platform with AI and new services.
Claire Turing
Claire Turing
18 Feb 2026
AuMEGA Metals has successfully upsized its institutional financing to C$30.1 million, anchored by Condire Investors who will hold nearly 20% of the company. The funds will accelerate exploration programs across its Newfoundland gold projects.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.
Ada Torres
Ada Torres
18 Feb 2026
PathKey.AI Ltd has responded to ASX inquiries about a recent spike in its share price and trading volume, confirming no undisclosed information is driving the market activity. The company points to its recent strategic update and funding completion as context for investor interest.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Cyclopharm has achieved a key milestone with Technegas approved for clinical use at the US National Institutes of Health, marking a strategic advance in its American expansion. Installation is imminent, leveraging a federal procurement framework that could broaden Technegas applications beyond pulmonary embolism.
Ada Torres
Ada Torres
18 Feb 2026
Caterpillar has finalized its acquisition of RPMGlobal, paying shareholders A$5.00 per share and prompting RPMGlobal’s removal from the ASX. This marks a significant shift in the mining software landscape.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Aeris Resources has withdrawn aspirational statements about extending mine life at its Tritton and Jaguar operations following its Peel Resources acquisition announcement, urging investors to exercise caution.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Chariot Resources Ltd has voluntarily suspended trading on the ASX as it finalises a significant financing arrangement, with an announcement expected by 20 February 2026.
Maxwell Dee
Maxwell Dee
18 Feb 2026